AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10468076 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine combined with limited exercise (140 microg/kg/min x 4 minutes during 6 minutes of modified Bruce treadmill exercise)
Number of subjects: 32
Study 7601918 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane applied at experimental sites
Number of subjects: 14
Study 7601918 — intervention group
Group type: COMPARATOR
Intervention: Control sites (no collagen barrier)
Number of subjects: 14
Study 1969560 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet ('Vivonex')
Number of subjects: 30
Study 1969560 — intervention group
Group type: COMPARATOR
Intervention: Polymeric diet ('Fortison')
Number of subjects: 30
Study 7004038 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I programme (square waves, 12 U/hr)
Number of subjects: 10
Study 7004038 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II programme (boluses, 120 U/hr)
Number of subjects: 10
Study 7004038 — intervention group
Group type: COMPARATOR
Intervention: Closed-loop programme
Number of subjects: 10
Study 7004038 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I programme
Number of subjects: 10
Study 7004038 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II programme
Number of subjects: 10
Study 7004038 — intervention group
Group type: EXPERIMENTAL
Intervention: Boluses
Number of subjects: 10
Study 7004038 — intervention group
Group type: EXPERIMENTAL
Intervention: Square waves
Number of subjects: 10
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Silica particles air‐abrasion
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaning with 70% alcohol
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: No bonding agent
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Monobond Plus
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Ceramic Primer
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond Universal
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐treatments
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonding agent
Number of subjects: 36
Study 31718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of pre‐treatments and bonding agent
Number of subjects: 36
Study 30521105 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic combination
Number of subjects: 99
Study 30521105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 28595137 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus chemotherapy
Number of subjects: 512
Study 28595137 — intervention group
Group type: COMPARATOR
Intervention: Control (chemotherapy without cetuximab)
Number of subjects: 512
Study 28595137 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF-mutated tumours
Number of subjects: 512
Study 28595137 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum IL-6 or CRP levels
Number of subjects: 512
Study 28595137 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in IL-6 and CRP levels
Number of subjects: 512
Study 26645895 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 779
Study 23989460 — intervention group
Group type: EXPERIMENTAL
Intervention: Provocative discography screening prior to surgery
Number of subjects: 310
Study 23989460 — intervention group
Group type: COMPARATOR
Intervention: No discography screening prior to surgery
Number of subjects: 310
Study 22133964 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5° distal root tipping bend for 4 weeks
Number of subjects: 15
Study 22133964 — intervention group
Group type: EXPERIMENTAL
Intervention: 15° distal root tipping bend for 4 weeks
Number of subjects: 15
Study 22133964 — intervention group
Group type: COMPARATOR
Intervention: Comparison of areas under pressure vs tension
Number of subjects: 15
Study 19405857 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 20
Study 19405857 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 16780556 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MU IFN + ribavirin for 12 months (Group 1)
Number of subjects: 97
Study 16780556 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 MU IFN + ribavirin for 12 months (Group 2)
Number of subjects: 97
Study 16780556 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MU IFN + ribavirin for 6 months (Group 3)
Number of subjects: 97
Study 16780556 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 MU IFN + ribavirin for 6 months (Group 4)
Number of subjects: 97
Study 14769600 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy
Number of subjects: 185
Study 14769600 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy plus autologous serum
Number of subjects: 185
Study 14769600 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 185
Study 11387289 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletes with varicocele
Number of subjects: 120
Study 11387289 — intervention group
Group type: COMPARATOR
Intervention: Non-athletes with varicocele
Number of subjects: 120
Study 11387289 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 120
Study 9401097 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinaverium bromide (50 mg) taken orally t.i.d. with food
Number of subjects: 40
Study 9401097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8285334 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% 2-chloroprocaine
Number of subjects: 60
Study 8285334 — intervention group
Group type: COMPARATOR
Intervention: 0.5% prilocaine
Number of subjects: 60
Study 3620281 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g kg‐1 absolute ethanol orally
Number of subjects: 24
Study 3620281 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control
Number of subjects: 24
Study 29699852 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free device
Number of subjects: 57
Study 29699852 — intervention group
Group type: COMPARATOR
Intervention: SC injection
Number of subjects: 57
Study 27289107 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention (physical training, cognitive behavioural training, participatory ergonomics)
Number of subjects: 594
Study 27289107 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 594
Study 24387916 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME)
Number of subjects: 21
Study 24387916 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 21
Study 22435889 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-conferencing with family caregiver participation
Number of subjects: 0
Study 22435889 — intervention group
Group type: COMPARATOR
Intervention: Standard meetings without family caregiver participation
Number of subjects: 0
Study 21256028 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) training 3×/week
Number of subjects: 113
Study 21256028 — intervention group
Group type: COMPARATOR
Intervention: Conventional dose of vitamin D (880 IU/d)
Number of subjects: 113
Study 21256028 — intervention group
Group type: COMPARATOR
Intervention: High dose of vitamin D (1600 IU/d)
Number of subjects: 113
Study 21256028 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) training
Number of subjects: 113
Study 21256028 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D supplementation (both doses)
Number of subjects: 113
Study 19228852 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin therapy (2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12)
Number of subjects: 5522
Study 19228852 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin therapy
Number of subjects: 5522
Study 19228852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5522
Study 16857528 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skills intervention
Number of subjects: 288
Study 16857528 — intervention group
Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 288
Study 14694031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin treatment
Number of subjects: 32
Study 14694031 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-field multifocal electroretinogram (WF-mfERG)
Number of subjects: 32
Study 14694031 — intervention group
Group type: COMPARATOR
Intervention: Control group (never received vigabatrin)
Number of subjects: 32
Study 10682411 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthrinse (Corsodyl)
Number of subjects: 12
Study 9493651 — intervention group
Group type: EXPERIMENTAL
Intervention: BALF-PIIINP
Number of subjects: 77
Study 9493651 — intervention group
Group type: COMPARATOR
Intervention: S-PIIINP
Number of subjects: 77
Study 9493651 — intervention group
Group type: EXPERIMENTAL
Intervention: BALF-PICP
Number of subjects: 77
Study 9493651 — intervention group
Group type: COMPARATOR
Intervention: S-PICP
Number of subjects: 77
Study 9493651 — intervention group
Group type: COMPARATOR
Intervention: S-ACE
Number of subjects: 77
Study 9493651 — intervention group
Group type: COMPARATOR
Intervention: S-IL-2R
Number of subjects: 77
Study 7839898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 600 mg/m2 intravenously (i.v.) on day 1
Number of subjects: 60
Study 7839898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside 100 mg/m2 subcutaneously (sc) 12 hourly for days 1‐5
Number of subjects: 60
Study 7839898 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of i.v. cyclophosphamide 600 mg/m2 on day 1 and cytosine arabinoside 100 mg/m2 12 hourly sc for days 1‐5
Number of subjects: 60
Study 7839898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide only
Number of subjects: 60
Study 7839898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside only
Number of subjects: 60
Study 7839898 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cytosine arabinoside and cyclophosphamide
Number of subjects: 60
Study 3128161 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil diet
Number of subjects: 0
Study 3128161 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil diet
Number of subjects: 0
Study 3128161 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-modified diets
Number of subjects: 0
Study 3128161 — intervention group
Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 0
Study 29720037 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 9
Study 29720037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 27578132 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA-enriched diet
Number of subjects: 39
Study 27578132 — intervention group
Group type: COMPARATOR
Intervention: PUFA-enriched diet
Number of subjects: 39
Study 26637992 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 40
Study 26637992 — intervention group
Group type: COMPARATOR
Intervention: Intravenously applied prostacyclin and bisphosphonate
Number of subjects: 40
Study 23778009 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan with amlodipine
Number of subjects: 2049
Study 23778009 — intervention group
Group type: COMPARATOR
Intervention: Candesartan with non-amlodipine CCBs
Number of subjects: 2049
Study 20565392 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.568 mg x ml(‐1) levobupivacaine plus sufentanil 0.45 microg x ml(‐1)
Number of subjects: 0
Study 20565392 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.136 mg x ml(‐1) levobupivacaine plus sufentanil 0.45 microg x ml(‐1)
Number of subjects: 0
Study 18416074 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with spinal Tui Na
Number of subjects: 30
Study 18416074 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 30
Study 16943467 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of levobupivacaine 0.25% at a rate of 5 ml per hour after an initial injection of 30 ml of levobupivacaine 0.5% with adrenaline 1:200 000.
Number of subjects: 16
Study 16943467 — intervention group
Group type: COMPARATOR
Intervention: Initial injection of 30 ml of levobupivacaine 0.5% with adrenaline 1:200 000.
Number of subjects: 16
Study 12948312 — intervention group
Group type: EXPERIMENTAL
Intervention: Small capsulorhexis (4.5 to 5.0 mm)
Number of subjects: 367
Study 12948312 — intervention group
Group type: COMPARATOR
Intervention: Large capsulorhexis (6.0 to 7.0 mm)
Number of subjects: 367
Study 10223022 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored health messages
Number of subjects: 272
Study 10223022 — intervention group
Group type: COMPARATOR
Intervention: Personalized health messages
Number of subjects: 272
Study 10223022 — intervention group
Group type: COMPARATOR
Intervention: General health messages
Number of subjects: 272
Study 10223022 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care (Control)
Number of subjects: 272
Study 8571186 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin prophylaxis
Number of subjects: 20
Study 8571186 — intervention group
Group type: COMPARATOR
Intervention: No heparin prophylaxis
Number of subjects: 20
Study 1914626 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal social support provided by trained volunteer coaches during prenatal and postpartum periods
Number of subjects: 46
Study 1914626 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no maternal social support)
Number of subjects: 46
Study 7259512 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcium chloride (5 mg/kg intermittent IV bolus)
Number of subjects: 0
Study 7259512 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcium chloride (0.5 mg/kg/min constant infusion)
Number of subjects: 0
Study 7259512 — intervention group
Group type: COMPARATOR
Intervention: No calcium chloride (control)
Number of subjects: 0
Study 30703519 — intervention group
Group type: EXPERIMENTAL
Intervention: Down-regulation neurofeedback (NF)
Number of subjects: 56
Study 30703519 — intervention group
Group type: EXPERIMENTAL
Intervention: Up-regulation neurofeedback (NF)
Number of subjects: 56
Study 30703519 — intervention group
Group type: COMPARATOR
Intervention: Neurofeedback training
Number of subjects: 56
Study 28233942 — intervention group
Group type: EXPERIMENTAL
Intervention: Just-in-time feedback targeting a 25% reduction in chew counts
Number of subjects: 18
Study 28233942 — intervention group
Group type: COMPARATOR
Intervention: Baseline chew count
Number of subjects: 18
Study 26067186 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg once daily
Number of subjects: 148
Study 26067186 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin 25 mg once daily
Number of subjects: 148
Study 23988802 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural corticosteroid injection of 80 mg methylprednisolone acetate
Number of subjects: 42
Study 23988802 — intervention group
Group type: COMPARATOR
Intervention: Epidural corticosteroid injection of 40 mg methylprednisolone acetate
Number of subjects: 42
Study 21131336 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding rehabilitation machine training (2 weeks) followed by conventional training (2 weeks)
Number of subjects: 30
Study 21131336 — intervention group
Group type: COMPARATOR
Intervention: Conventional training only
Number of subjects: 30
Study 19297384 — intervention group
Group type: COMPARATOR
Intervention: Increasing education categories
Number of subjects: 27207
Study 19297384 — intervention group
Group type: COMPARATOR
Intervention: Increasing income categories
Number of subjects: 27207
Study 18037652 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral appliance therapy
Number of subjects: 103
Study 18037652 — intervention group
Group type: COMPARATOR
Intervention: CPAP therapy
Number of subjects: 103
Study 15136320 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose antioxidants
Number of subjects: 4753
Study 15136320 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc
Number of subjects: 4753
Study 15136320 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity worse than 20/40 in 1 eye
Number of subjects: 4753
Study 15136320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear opacity
Number of subjects: 4753
Study 15136320 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 4753
Study 11181667 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 6 mg/m(2)/d
Number of subjects: 369
Study 11181667 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 18 mg/m(2)/d
Number of subjects: 369
Study 11181667 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 150 mg/m(2)/d
Number of subjects: 369
Study 11181667 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose corticosteroids (prednisolone 40 mg/m(2)/d or dexamethasone < 6 mg/m(2)/d)
Number of subjects: 369
Study 11181667 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids (dexamethasone 18 or 150 mg/m(2)/d)
Number of subjects: 369
Study 11181667 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose corticosteroids
Number of subjects: 369
Study 11181667 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids
Number of subjects: 369
Study 9134141 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg, maximum dose 12 mg)
Number of subjects: 52
Study 9134141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 7700067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 0
Study 7700067 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study 3428347 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 750 mg theophylline (2 capsules Euphylong 375)
Number of subjects: 0
Study 3428347 — intervention group
Group type: COMPARATOR
Intervention: Intravenous aminophylline infusion corresponding to 506 mg theophylline over 8 h (63 mg.h‐1)
Number of subjects: 0
Study 3428347 — intervention group
Group type: COMPARATOR
Intervention: Intravenous aminophylline infusion corresponding to 749 mg theophylline over 14 h, with a reduction in infusion rate from 69 to 33 mg.h‐1 after 8 h
Number of subjects: 0
Study 29167980 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous platelet concentrate (PC) injection
Number of subjects: 40
Study 29167980 — intervention group
Group type: COMPARATOR
Intervention: Control group (observation)
Number of subjects: 40
Study 28461350 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved communication and behaviorally informed nudges
Number of subjects: 0
Study 28461350 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 25746022 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive intervention
Number of subjects: 0
Study 25746022 — intervention group
Group type: COMPARATOR
Intervention: Delayed invasive approach
Number of subjects: 0
Study 24282871 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Cavity Protection Regular toothpaste plus 1.4% potassium oxalate mouthrinse (LADS)
Number of subjects: 56
Study 24282871 — intervention group
Group type: COMPARATOR
Intervention: Crest Cavity Protection Regular toothpaste
Number of subjects: 56
Study 24282871 — intervention group
Group type: COMPARATOR
Intervention: Colgate Cavity Protection Regular toothpaste
Number of subjects: 56
Study 22008088 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion with a supplemental flexible pedicle screw system to protect the adjacent segment ("topping off")
Number of subjects: 0
Study 22008088 — intervention group
Group type: COMPARATOR
Intervention: Conventional fusion
Number of subjects: 0
Study 18208741 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomaterial to strengthen laparotomy closures in high-risk patients
Number of subjects: 0
Study 17090992 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of isoflavone (soybean) and 1,500 mg of calcium for nine months
Number of subjects: 38
Study 17090992 — intervention group
Group type: COMPARATOR
Intervention: 1,500 mg of calcium only for nine months
Number of subjects: 38
Study 12950424 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection
Number of subjects: 44
Study 12950424 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 44
Study 10802159 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple insulin injection therapy (MIT)
Number of subjects: 110
Study 10802159 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin injection therapy (CIT)
Number of subjects: 110
Study 9162448 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (50 mmol/day)
Number of subjects: 30
Study 9162448 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sodium diet (250 mmol/day)
Number of subjects: 30
Study 1999883 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 25 micrograms
Number of subjects: 23
Study 1999883 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 50 micrograms
Number of subjects: 23
Study 1999883 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 100 micrograms
Number of subjects: 23
Study 1999883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 6240568 — intervention group
Group type: COMPARATOR
Intervention: GRF1-44
Number of subjects: 5
Study 6240568 — intervention group
Group type: COMPARATOR
Intervention: GRF1-40
Number of subjects: 5
Study 6240568 — intervention group
Group type: COMPARATOR
Intervention: GRF1-29
Number of subjects: 5
Study 6240568 — intervention group
Group type: COMPARATOR
Intervention: GRF1-44 (administered over 2 days in 6- and 18-h intervals)
Number of subjects: 5
Study 30309789 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based health education plus mindfulness training (HE-MT)
Number of subjects: 53
Study 30309789 — intervention group
Group type: COMPARATOR
Intervention: Health education plus attention control (HE-AC)
Number of subjects: 53
Study 29200185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine
Number of subjects: 831